Article
AbbVie Sues BeiGene Over Imbruvica Patent
On June 15, AbbVie filed a lawsuit against BeiGene, claiming that BeiGene's Brukinsa has infringed a patent on its blood cancer drug Imbruvica.
AFD China
Use advanced search filters to refine your search
Showing 1–20 of 1055 results